SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-067760
Filing Date
2018-11-13
Accepted
2018-11-13 09:00:38
Documents
3
Period of Report
2018-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40103_18k.htm 8-K 21685
2 EX-99.1 a18-40103_1ex99d1.htm EX-99.1 113342
3 GRAPHIC g401031mmi001.jpg GRAPHIC 3830
  Complete submission text file 0001104659-18-067760.txt   141581
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 181175507
SIC: 2834 Pharmaceutical Preparations